News Website

Harvard scientists create menstruating mice: A discovery that could rewrite women’s reproductive health science - MSN

Harvard scientists create menstruating mice: A discovery that could rewrite women’s reproductive health science MSN

Published: Nov. 7, 2025, 1:20 p.m.

Read Full Article

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - The Malaysian Reserve

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health The Malaysian Reserve

Published: Nov. 6, 2025, 8:25 p.m.

Read Full Article

Association Between Previous Surgical Treatment and Outcomes of Repeat Endometriosis Surgery - medtalks.in

Association Between Previous Surgical Treatment and Outcomes of Repeat Endometriosis Surgery medtalks.in

Published: Nov. 6, 2025, 11:13 a.m.

Read Full Article

Is There Really a Cancer Epidemic in Younger Adults? - Medscape

Is There Really a Cancer Epidemic in Younger Adults? Medscape

Published: Nov. 6, 2025, 10:07 a.m.

Read Full Article

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - Fidelity

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health Fidelity

Published: Nov. 6, 2025, 4:32 a.m.

Read Full Article

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - PR Newswire

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health PR Newswire

Published: Nov. 6, 2025, 4:08 a.m.

Read Full Article

Hormonal contraceptives linked to higher breast cancer risk, study finds - The Eastleigh Voice

Hormonal contraceptives linked to higher breast cancer risk, study finds The Eastleigh Voice

Published: Nov. 6, 2025, 3:53 a.m.

Read Full Article

Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results - The Manila Times

Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results The Manila Times

Published: Nov. 5, 2025, 9:37 p.m.

Read Full Article

Harvard scientists create menstruating mice: A discovery that could rewrite women’s reproductive health s - Times of India

Harvard scientists create menstruating mice: A discovery that could rewrite women’s reproductive health s Times of India

Published: Nov. 5, 2025, 4:30 p.m.

Read Full Article

Will Tesco PLC (Common Stock) (TCO2) stock test record highs in 2025 - Earnings Recap Report & Verified Entry Point Signals - fcp.pa.gov.br

Will Tesco PLC (Common Stock) (TCO2) stock test record highs in 2025 - Earnings Recap Report & Verified Entry Point Signals fcp.pa.gov.br

Published: Nov. 5, 2025, 2:39 p.m.

Read Full Article

Latest Articles

Harvard scientists create menstruating mice: A discovery that could rewrite women’s reproductive health science - MSN

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - The Malaysian Reserve

Association Between Previous Surgical Treatment and Outcomes of Repeat Endometriosis Surgery - medtalks.in

Is There Really a Cancer Epidemic in Younger Adults? - Medscape

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - Fidelity

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - PR Newswire

Hormonal contraceptives linked to higher breast cancer risk, study finds - The Eastleigh Voice

Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results - The Manila Times

Harvard scientists create menstruating mice: A discovery that could rewrite women’s reproductive health s - Times of India

Will Tesco PLC (Common Stock) (TCO2) stock test record highs in 2025 - Earnings Recap Report & Verified Entry Point Signals - fcp.pa.gov.br

Subscribe to Our Newsletter